MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors
MetaVia Inc. (NASDAQ: MTVA) completed a 1-for-11 reverse stock split on December 4, 2025, sending its share price to $8.18, up nearly 12% in 24 hours. The company, now valued at about $17 million, remains early-stage with no product revenue and a staff of nine. Trading volume and volatility remain high. MetaVia’s lead drug candidates target obesity and metabolic liver disease.
